Related Experiment Videos
Long-term controlled navel administration of testosterone
Journal of Pharmaceutical Sciences
|August 1, 1984
Summary
A novel bandage-type device delivers testosterone continuously for over a month, effectively regulating male fertility. This controlled release ensures steady plasma levels and high bioavailability.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Drug Delivery Systems
Background:
- Male fertility is influenced by sustained testosterone levels.
- Existing methods for testosterone administration may lack long-term control.
- Need for a reliable, extended-release testosterone delivery system.
Purpose of the Study:
- To develop and evaluate a novel disk-shaped, bandage-type device for controlled, long-term testosterone release.
- To assess the in vitro and in vivo performance of the testosterone-releasing device.
Main Methods:
- Development of a disk-shaped, bandage-type device for testosterone delivery.
- In vitro drug elution studies to determine release kinetics.
- In vivo studies in rhesus monkeys to assess plasma levels and urinary excretion over 46 days.
Main Results:
- In vitro studies confirmed a constant release profile of testosterone.
- In vivo studies demonstrated steady plasma testosterone levels and constant urinary excretion rates for over 32 days.
- Systemic bioavailability was more than twofold higher compared to direct application or placebo devices, with over 90% dose recovery within a month.
Conclusions:
- The developed bandage-type device provides a controlled and sustained release of testosterone.
- This system offers improved systemic bioavailability and efficacy for potential male fertility regulation.
- The in vitro and in vivo data support the device's potential for long-term therapeutic applications.